Infections with human cytomegalovirus (HCMV) are a major cause of morbidity and mortality in humans with acquired or developmental deficits in innate and adaptive immunity. In the normal immunocompetent host, symptoms rarely accompany acute infections, although prolonged virus shedding is frequent. Virus persistence is established in all infected individuals and appears to be maintained by both a chronic productive infections as well as latency with restricted viral gene expression. The contributions of the each of these mechanisms to the persistence of this virus in the individual is unknown but frequent virus shedding into the saliva and genitourinary tract likely accounts for the near universal incidence of infection in most populations in the world. The pathogenesis of disease associated with acute HCMV infection is most readily attributable to lytic virus replication and end organ damage either secondary to virus replication and cell death or from host immunological responses that target virus-infected cells. Antiviral agents limit the severity of disease associated with acute HCMV infections, suggesting a requirement for virus replication in clinical syndromes associated with acute infection. End organ disease secondary to unchecked virus replication can be observed in infants infected in utero, allograft recipients receiving potent immunosuppressive agents, and patients with HIV infections that exhibit a loss of adaptive immune function. In contrast, diseases associated with chronic or persistent infections appear in normal individuals and in the allografts of the transplant recipient. The manifestations of these infections appear related to chronic inflammation, but it is unclear if poorly controlled virus replication is necessary for the different phenotypic expressions of disease that are reported in these patients. Although the relationship between HCMV infection and chronic allograft rejection is well known, the mechanisms that account for the role of this virus in graft loss are not well understood. However, the capacity of this virus to persist in the midst of intense inflammation suggests that its persistence could serve as a trigger for the induction of host-vs-graft responses or alternatively host responses to HCMV could contribute to the inflammatory milieu characteristic of chronic allograft rejection.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adam SG, Caraux A, Fodil-Cornu N, Loredo-Osti JC, Lesjean-Pottier S, Jaubert J, Bubic I, Jonjic S, Guenet JL, Vidal SM, Colucci F (2006) Cmv4, a new locus linked to the NK cell gene complex, controls innate resistance to cytomegalovirus in wild-derived mice. J Immunol 176:5478–5485.
Adler SP (1989) Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers. N Engl J Med 321:1290–1296.
Adler SP (1991) Cytomegalovirus and child day care: risk factors for maternal infection. Pediatr Infect Dis J 10:590.
Ahlfors K, Ivarsson SA, Harris S (1999) Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis 31:443–457.
Ahlfors K, Ivarsson SA, Harris S (2001) Secondary maternal cytomegalovirus infection–A significant cause of congenital disease. Pediatrics 107:1227–1228.
Alcami A, Koszinowski UH (2000) Viral mechanisms of immune evasion. Immunol Today 21:447–455.
Alford CA, Pass RF (1981) Epidemiology of chronic congenital and perinatal infections of man. Clin Perinatoly 8:397–414.
Anderson KS, Amos CS, Boppana S, Pass R (1996) Ocular abnormalities in congenital cytomegalovirus infection. J Am Optometr Assoc 67:273–278.
Andoniou CE, Degli-Esposti MA (2006) Insights into the mechanisms of CMV-mediated interference with cellular apoptosis. Immunol Cell Biol 84:99–106.
Anonymous (1999) Congenital syphilis - United States, 1998. MMWR Morb Mortal Wkly Rep 48:757–761.
Arkonac B, Mauck KA, Chou S, Hosenpud JD (1997) Low multiplicity cytomegalovirus infection of human aortic smooth muscle cells increases levels of major histocompatibility complex class I antigens and induces a proinflammatory cytokine milieu in the absence of cytopathology. J Heart Lung Transplant 16:1035–1045.
Arribas JR, Storch GA, Clifford DB, Tselis AC (1996) Cytomegalovirus encephalitis. Ann Intern Med 125:577–587.
Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J (1997) Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112–116.
Baas IO, Offerhaus JA, El-Deiry WS, Wu TC, Hutchins GM, Kasper EK, Baughman KL, Baumgartner WA, Chiou CJ, Hayward GS, Hruban RH (1996) The WAF1-mediated p53 growth-suppressor pathway is intact in the coronary arteries of heart transplant recipients. Human Pathol 27:324–329.
Bale JF Jr, Petheram SJ, Souza IE, Murph JR (1996) Cytomegalovirus reinfection in young children. J Pediatr 128:347–352.
Bale JF Jr, Zimmerman B, Dawson JD, Souza IE, Petheram SJ, Murph JR (1999) Cytomegalovirus transmission in child care homes. Arch Pediatr Adoles Med 153:75–79.
Barel MT, Ressing M, Pizzato N, van Leeuwen D, Le Bouteiller P, Lenfant F, Wiertz EJ (2003) Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. J Immunol 171:6757–6765.
Barkovich AJ, Lindan CE (1994) Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. Am J Neuroradiol 15:703–715.
Baroncelli S, Barry PA, Capitanio JP, Lerche NW, Otsyula M, Mendoza SP (1997) Cytomegalovirus and simian immunodeficiency virus coinfection: longitudinal study of antibody responses and disease progression. J Acquir Immune Defic Syndr Human Retrovirol 15:5–15.
Barry PA, Lockridge KM, Salamat S, Tinling SP, Yue Y, Zhou SS, Gospe SM Jr, Britt WJ, Tarantal AF (2006) Nonhuman primate models of intrauterine cytomegalovirus infection. ILAR J 47:49–64.
Barry SM, Johnson MA, Janossy G (2000) Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited. Bone Marrow Transplant 26:591–597.
Becroft DM (1981) Prenatal cytomegalovirus infection: epidemiology, pathology and pathogenesis. Perspect Pediatr Pathol 6:203–241.
Bernstein DI, Bourne N (1999) Animal models for cytomegalovirus infection: Guinea-pig CMV. In: Zak MS (ed) Handbook of animal models of infection. Academic Press, London, pp 935–941.
Berry NJ, Burns DM, Wannamethee G, Grundy JE, Lui SF, Prentice HG, Griffiths PD (1988) Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus, and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseases. J Med Virol 24:385–393.
Bia FJ, Griffith BP, Fong CK, Hsiung GD (1983) Cytomegaloviral infections in the guinea pig: experimental models for human disease. Rev Infect Dis 5:177–195.
Biassoni R, Cantoni C, Pende D, Sivori S, Parolini S, Vitale M, Bottino C, Moretta A (2001) Human natural killer cell receptors and co-receptors. Immunol Rev 181:203–214.
Billstrom MA, Lehman LA, Scott Worthen G (1999) Depletion of extracellular RANTES during human cytomegalovirus infection of endothelial cells. Am J Respiry Cell Mol Biol 21:163–167.
Billstrom Schroeder M, Worthen GS (2001) Viral regulation of RANTES expression during human cytomegalovirus infection of endothelial cells. J Virol 75:3383–3390.
Biron CA, Byron KS, Sullivan JL (1989) Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731–1735.
Blankenberg S, Rupprecht HJ, Bickel C, Espinola-Klein C, Rippin G, Hafner G, Ossendorf M, Steinhagen K, Meyer J (2001) Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation 103:2915–2921.
Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L, Arenzana-Seisdedos F, Virelizier JL, Michelson S (1998) Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 188:855–866.
Boeckh M, Leisenring W, Riddell SR, Bowden RA, Huang ML, Myerson D, Stevens-Ayers T, Flowers ME, Cunningham T, Corey L (2003) Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 101:407–414.
Boivin G, Handfield J, Toma E, Murray G, Lalonde R, Bergeron MG (1998) Comparative evaluation of the cytomegalovirus DNA load in polymorphonuclear leukocytes and plasma of human immunodeficiency virus-infected subjects. J Infect Dis 177:355–360.
Bolovan-Fritts CA, Mocarski ES, Wiedeman JA (1999) Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93:394–398.
Bolovan-Fritts CA, Trout RN, Spector SA (2007) High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage. Blood 110:1857–1863.
Bonatti H, Tabarelli W, Ruttmann E, Kafka R, Larcher C, Hofer D, Klaus A, Laufer G, Geltner C, Margreiter R, Muller L, Antretter H (2004) Impact of cytomegalovirus match on survival after cardiac and lung transplantation. Am Surg 70:710–714.
Boppana SB, Britt WJ (1996) Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells. Virology 222:293–296.
Boppana SB, Fowler KB, Pass RF, Britt WJ, Stagno S, Alford CA (1992) Newborn findings and outcome in children with symptomatic congenital CMV infection. Pediatr Res 31:158A.
Boppana SB, Fowler KB, Vaid Y, Hedlund G, Stagno S, Britt WJ, Pass RF (1997) Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 99:409–414.
Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF (1999) Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 104:55–60.
Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ (2001) Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344:1366–1371.
Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD, Britt WJ (2005) Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 146:817–823.
Bourne N, Schleiss M, Bravo F, Bernstein D (2001) Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection. J Infect Dis 183:59–64.
Bowden RA (1995) Transfusion-transmitted cytomegalovirus infection. Hematol Oncol Clin N Am 9:155–166.
Bowden RA, Day LM, Amos DE, Meyers JD (1987) Natural cytotoxic activity against cytomegalovirus-infected target cells following marrow transplantation. Transplantation 44:504–508.
Bowen EF, Wilson P, Atkins M, Madge S, Griffiths PD, Johnson MA, Emery VC (1995) Natural history of untreated cytomegalovirus retinitis. Lancet 346:1671–1673.
Britt WJ, Harrison C (1994) Identification of an abundant disulfide-linked complex of glycoproteins in the envelope of guinea pig cytomegalovirus. Virology 201:294–302.
Britt WJ, Mach M (1996) Human cytomegalovirus glycoproteins. Intervirology 39:401–412.
Britt WJ, Jarvis MA, Drummond DD, Mach M (2005) Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B. J Virol 79:4066–4079.
Brune W, Hasan M, Krych M, Bubic I, Jonjic S, Koszinowski UH (2001) Secreted virus-encoded proteins reflect murine cytomegalovirus productivity in organs. J Infect Dis 184:1320–1324.
Bubic I, Wagner M, Krmpoti A, Saulig T, Kim S, Yokoyama WM, Jonji S, Koszinowski UH (2004) Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 78:7536–7544.
Buggage RR, Chan CC, Matteson DM, Reed GF, Whitcup SM (2000) Apoptosis in cytomegalovirus retinitis associated with AIDS. Curr Eye Res 21:721–729.
Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk HD, Lehmkuhl H, Kern F (2005) Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 201:1031–1036.
Burns LJ, Pooley JC, Walsh DJ, Vercellotti GM, Weber ML, Kovacs A (1999) Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation 67:137–144.
Caliendo AM, Schuurman R, Yen-Lieberman B, Spector SA, Andersen J, Manjiry R, Crumpacker C, Lurain NS, Erice A, The CMV Working Group of the Complications of HIV Disease Rac ACTG (2001) Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol 39:1334–1338.
Cantrell SR, Bresnahan WA (2006) Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J Virol 80:6188–6191.
Carstens J, Andersen HK, Spencer E, Madsen M (2006) Cytomegalovirus infection in renal transplant recipients. Transpl Infect Dis 8:203–212.
Cassady KA (2005) Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection. J Virol 79:8707–8715.
Castro LA, Gokel JM, Thoenes G, Frosner G, Land W, Hillebrand G, Gurland HJ (1983) Renal changes in cytomegalovirus infection. Proc Eur Dial Transplant Assoc 19:500–504.
Chambers J, Angulo A, Amaratunga D, Guo H, Jiang Y, Wan JS, Bittner A, Frueh K, Jackson MR, Peterson PA, Erlander MG, Ghazal P (1999) DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol 73:5757–5766.
Chandler SH, Holmes KK, Wentworth BB, Gutman LT, Wiesner PJ, Alexander ER, Handsfield HH (1985) The epidemiology of cytomegaloviral infection in women attending a sexually transmitted disease clinic. J Infect Dis 152:597–605.
Chandler SH, Handsfield HH, McDougall JK (1987) Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted diseases. J Infect Dis 155:655–660.
Chatterjee A, Harrison CJ, Britt WJ, Bewtra C (2001) Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs. J Infect Dis 183:1547–1553.
Chen JH, Mao YY, He Q, Wu JY, Lv R (2005) The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection. Transplant Proc 37:4203–4207.
Child S, Jarrahian S, Harper V, Geballe A (2002) Complementation of vaccinia virus lacking the double stranded RNA-binding protein gene E3L by human cytomegalovirus. J Virol 76:4912–4918.
Child SJ, Hanson LK, Brown CE, Janzen DM, Geballe AP (2006) Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins. J Virol 80:10173–10180.
Chou S (1986) Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N Engl J Med 314:1418–1423.
Chou SW (1987) Cytomegalovirus infection and reinfection transmitted by heart transplantation. J Infect Dis 155:1054–1056.
Chung H, Kim KH, Kim JG, Lee SY, Yoon YH (2007) Retinal complications in patients with solid organ or bone marrow transplantations. Transplantation 83:694–699.
Cinatl J Jr, Cinatl J, Vogel JU, Rabenau H, Kornhuber B, Doerr HW (1996) Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology 39:259–269.
Cinatl J Jr, Kotchetkov R, Scholz M, Cinatl J, Vogel JU, Driever PH, Doerr HW (1999) Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. Am J Pathol 155:285–292.
Cohen JI, Corey GR (1985) Cytomegalovirus infection in the normal host. Medicine 64:100–114.
Collier AC, Chandler SH, Handsfield HH, Corey L, McDougall JK (1989) Identification of multiple strains of cytomegalovirus in homosexual men. J Infect Dis 159:123–126.
Collier AC, Handsfield HH, Ashley R, Roberts PL, DeRouen T, Meyers JD, Corey L (1995) Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J Infect Dis 171:33–38.
Cook M, Briggs D, Craddock C, Mahendra P, Milligan D, Fegan C, Darbyshire P, Lawson S, Boxall E, Moss P (2006) Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 107: 1230–1232.
Cope AV, Sabin C, Burroughs A, Rolles K, Griffiths PD, Emery VC (1997) Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J Infect Dis 176:1484–1490.
Craigen JL, Yong KL, Jordan NJ, MacCormac LP, Westwick J, Akbar AN, Grundy JE (1997) Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology 92:138–145.
Dahle AF, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF (2000) Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 11:283–290.
De La Melena VT, Kreklywich CN, Streblow DN, Yin Q, Cook JW, Soderberg-Naucler C, Bruggeman CA, Nelson JA, Orloff SL (2001) Kinetics and development of CMV-accelerated transplant vascular sclerosis in rat cardiac allografts is linked to early increase in chemokine expression and presence of virus. Transplant Proc 33:1822–1823.
de Mello AL, Ferreira EC, Vilas Boas LS, Pannuti CS (1996) Cytomegalovirus infection in a day-care center in the municipality of Sao Paulo. Rev Inst Med Trop Sao Paulo 38:165–169.
Dengler TJ, Raftery MJ, Werle M, Zimmermann R, Schonrich G (2000) Cytomegalovirus infection of vascular cells induces expression of pro-inflammatory adhesion molecules by paracrine action of secreted interleukin-1beta. Transplantation 69:1160–1168.
Dieterich DT, Rahmin M (1991) Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J AIDS 4: S29–S35.
Doctor S, Friedman S, Dunn MS, Asztalos EV, Wylie L, Mazzulli T, Vearncombe M, O’Brien K (2005) Cytomegalovirus transmission to extremely low-birthweight infants through breast milk. Acta Paediatr 94:53–58.
Drew WL, Mintz L (1984) Cytomegalovirus infection in healthy and immune-deficient homosexual men. In: Ma P, Armstrong D (eds) The acquired immune deficiency syndrome and infections of homosexual men. Yorke Medical Books, New York, pp 117–123.
Drew WL, Mintz L, Miner RC, Sands M, Ketterer B (1981) Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis 143:188–192.
Drew WL, Sweet ES, Miner RC, Mocarski ES (1984) Multiple infections by cytomegalovirus in patients with acquired immune deficiency syndrome: documentation by Southern blot hybridization. J Infect Dis 150:952–953.
Drover S, Kovats S, Masewicz S, Blum JS, Nepom GT (1998) Modulation of peptide-dependent allospecific epitopes on HLA-DR4 molecules by HLA-DM. Human Immunol 59:77–86.
Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V, Zhu H, Liu F (2003) Functional profiling of the human cytomegalovirus genome. Proc Natl Acad Sci USA 100:14223–14228.
Emery VC, Sabin C, Feinberg JE, Grywacz M, Knight S, Griffiths PD (1999) Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease survival. J Infect Dis 180:695–701.
Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD (2000) Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.[comment]. Lancet. 355:2032–2036.
Evans PC, Coleman N, Wreghitt TG, Wight DG, Alexander GJ (1999) Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts. J Hepatol 31:913–920.
Evans PC, Soin A, Wreghitt TG, Taylor CJ, Wight DG, Alexander GJ (2000) An association between cytomegalovirus infection and chronic rejection after liver transplantation. Transplantation 69:30–35.
Everett JP, Hershberger RE, Norman DJ, Chou S, Ratkovec RM, Cobanoglu A, Ott GY, Hosenpud JD (1992) Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant 11:S133–S137.
Fabricant CG, Fabricant J (1999) Atherosclerosis induced by infection with Marek’s disease herpesvirus in chickens. Am Heart J 138: S465–S468.
Fabricant CG, Fabricant J, Litrenta MM, Minick CR (1978) Virus-induced atherosclerosis. J Exp Med 148:335–340.
Falagas ME, Paya C, Ruthazer R, Badley A, Patel R, Wiesner R, Griffith J, Freeman R, Rohrer R, Werner BG, Snydman DR (1998) Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis. Transplantation 66:1020–1028.
Fateh-Moghadam S, Bocksch W, Wessely R, Jager G, Hetzer R, Gawaz M (2003) Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy. Transplantation 76:1470–1474.
Fish KN, Soderberg-Naucler C, Mills LK, Stenglein S, Nelson JA (1998) Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 72:5661–5668.
Fisher S, Genbacev O, Maidji E, Pereira L (2000) Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 74:6808–6820.
Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, Sgarabotto D, Torre-Cisneros J, Uknis ME (2007) Cytomegalovirus in transplantation - challenging the status quo. Clin Transplant 21:149–158.
Fortunato EA, Spector DH (1998) p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol 72:2033–2039.
Fowler KB, Pass RF (1991) Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infection. J Infect Dis 164:259–264.
Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326:663–667.
Francis ND, Boylston AW, Roberts AH, Parkin JM, Pinching AJ (1989) Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS. J Clin Pathol 42:1055–1064.
French AR, Yokoyama WM (2003) Natural killer cells and viral infections. Curr Opin Immunol 15:45–51.
French AR, Pingel JT, Wagner M, Bubic I, Yang L, Kim S, Koszinowski U, Jonjic S, Yokoyama WM (2004) Escape of mutant double-stranded DNA virus from innate immune control. Immunity 20:747–756.
Froberg MK, Adams A, Seacotte N, Parker-Thornburg J, Kolattukudy P (2001) Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1. Circ Res 89:1224–1230.
Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE (1992) Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis 166:1223–1227.
Gehrz RC, Marker SC, Knorr SO, Kalis JM, Balfour HH Jr (1977) Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers. Lancet 2:844–847.
Gentile G, Picardi A, Capobianchi A, Spagnoli A, Cudillo L, Dentamaro T, Tendas A, Cupelli L, Ciotti M, Volpi A, Amadori S, Martino P, de Fabritiis P (2006) A prospective study comparing quantitative cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation. BMC Infect Dis 6:167.
Gerna G, Zavattoni M, Baldanti F, Furione M, Chezzi L, Revello MG, Percivalle E (1998) Circulating cytomegalic endothelial cells are associated with high human cytomegalovirus (HCMV) load in AIDS patients with late-stage disseminated HCMV disease. J Med Virol 55:64–74.
Gerna G, Percivalle E, Baldanti F, Sozzani S, Lanzarini P, Genini E, Lilleri D, Revello MG (2000) Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol 74:5629–5638.
Gewurz BE, Gaudet R, Tortorella D, Wang EW, Ploegh HL (2001) Virus subversion of immunity: a structural perspective. Curr Opin Immunol 13:442–450.
Gibson L, Piccinini G, Lilleri D, Revello MG, Wang Z, Markel S, Diamond DJ, Luzuriaga K (2004) Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. J Immunol 172:2256–2264.
Gibson L, Dooley S, Trzmielina S, Somasundaran M, Fisher D, Revello MG, Luzuriaga K (2007) Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants. J Infect Dis 195:1789–1798.
Gillespie GM, Wills MR, Appay V, O’Callaghan C, Murphy M, Smith N, Sissons P, Rowland-Jones S, Bell JI, Moss PA (2000) Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol 74:8140–8150.
Glasgow BJ, Weisberger AK (1994) A quantitative and cartographic study of retinal microvasculopathy in acquired immunodeficiency syndrome. Am J Ophthalmol 118:46–56.
Gnann JW, Ahlmen J, Svalander C et al (1988) Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am J Pathol 132:239–248.
Goldmacher VS (2002) vMIA, a viral inhibitor of apoptosis targeting mitochondria. Biochimie 84:177–185.
Gor D, Sabin C, Prentice HG, Vyas N, Man S, Griffiths PD, Emery VC (1998) Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplant 21:597–605.
Gorman S, Harvey NL, Moro D, Lloyd ML, Voigt V, Smith LM, Lawson MA, Shellam GR (2006) Mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice. J Gen Virol 87:1123–1132.
Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, Emery V, Colhoun HM, Vallance P (2003) Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 108:678–683.
Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE (1989) Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561–3566.
Griffith BP, Lucia HL, Bia FJ, Hsiung GD (1981) Cytomegalovirus-induced mononucleosis in guinea pigs. Infect Immun 32:857–863.
Griffith BP, McCormick SR, Fong CK, Lavallee JT, Lucia HL, Goff E (1985) The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol 55:402–409.
Griffith BP, McCormick SR, Booss J, Hsiung GD (1986) Inbred guinea pig model of intrauterine infection with cytomegalovirus. Am J Pathol 122:112–119.
Griffiths PD, Baboonian C (1984) A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaecol 91:307–315.
Grundy JE, Shanley JD, Griffiths PD (1987) Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet 2:996–999.
Grundy JE, Lui SF, Super M, Berry NJ, Sweny P, Fernando ON, Moorhead J, Griffiths PD (1988) Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 2:132–135.
Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL (1998) Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis 177:1465–1474.
Gyorkey F, Melnick JL, Guinn GA, Gyorkey P, DeBakey ME (1984) Herpesviridae in the endothelial and smooth muscle cells of the proximal aorta in arteriosclerotic patients. Exp Mol Pathol 40:328–339.
Haerter G, Manfras BJ, de Jong-Hesse Y, Wilts H, Mertens T, Kern P, Schmitt M (2004) Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis. Clin Infect Dis 39:e88–94.
Hahn G, Revello MG, Patrone M, Percivalle E, Campanini G, Sarasini A, Wagner M, Gallina A, Milanesi G, Koszinowski U, Baldanti F, Gerna G (2004) Human cytomegalovirus UL131–128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78:10023–10033.
Hakki M, Geballe AP (2005) Double-stranded RNA binding by human cytomegalovirus pTRS1. J Virol 79:7311–7318.
Hakki M, Marshall EE, De Niro KL, Geballe AP (2006) Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1. J Virol 80:11817–11826.
Halwachs-Baumann G, Wilders-Truschnig M, Desoye G, Hahn T, Kiesel L, Klingel K, Rieger P, Jahn G, Sinzger C (1998) Human trophoblast cells are permissive to the complete replicative cycle of human cytomegalovirus. J Virol 72:7598–7602.
Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G (2001) Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 357:513–518.
Han CP, Tsao YP, Sun CA, Ng HT, Chen SL (1997) Human papillomavirus, cytomegalovirus and herpes simplex virus infections for cervical cancer in Taiwan. Cancer Lett 120:217–221.
Handsfield HH, Chandler SH, Caine VA, Meyers JD, Corey L, Medeiros E, McDougall JK (1985) Cytomegalovirus infection in sex partners: evidence for sexual transmission. J Infect Dis 151:344–348.
Harris S, Ahlfors K, Ivarsson S, Lemmark B, Svanberg L (1984) Congenital cytomegalovirus infection and sensorineural hearing loss. Ear Hear 5:352–355.
Harrison CJ, Caruso N (2000) Correlation of maternal and pup NK-like activity and TNF responses against cytomegalovirus to pregnancy outcome in inbred guinea pigs. J Med Virol 60:230–236.
Harrison CJ, Myers MG (1990) Relation of maternal CMV viremia and antibody response to the rate of congenital infection and intrauterine growth retardation. J Med Virol 31:222–228.
Hartmann A, Sagedal S, Hjelmesaeth J (2006) The natural course of cytomegalovirus infection and disease in renal transplant recipients. Transplantation 82: S15–S17.
Hasan M, Krmpotic A, Ruzsics Z, Bubic I, Lenac T, Halenius A, Loewendorf A, Messerle M, Hengel H, Jonjic S, Koszinowski UH (2005) Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol 79:2920–2930.
Hassan-Walker AF, Mattes FM, Griffiths PD, Emery VC (2001) Quantity of cytomegalovirus DNA in different leukocyte populations during active infection in vivo and the presence of gB and UL18 transcripts. J Med Virol 64:283–289.
Helantera I, Koskinen P, Finne P, Loginov R, Kyllonen L, Salmela K, Gronhagen-Riska C, Lautenschlager I (2006) Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival. Transpl Int 19:893–900.
Hemmings DG, Kilani R, Nykiforuk C, Preiksaitis J, Guilbert LJ (1998) Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts. J Virol 72:4970–4979.
Hendrix MG, Dormans PH, Kitslaar P, Bosman F, Bruggeman CA (1989) The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol 134:1151–1157.
Hendrix MG, Daemen M, Bruggeman CA (1991) Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol 138:563–567.
Herrera GA, Alexander RW, Cooley CF, Luke RG, Kelly DR, Curtis JJ, Gockerman JP (1986) Cytomegalovirus glomerulopathy: a controversial lesion. Kidney Int 29:725–733.
Hicks T, Fowler K, Richardson M, Dahle A, Adams L, Pass R (1993) Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatr 123:779–782.
Hobom U, Brune W, Messerle M, Hahn G, Koszinowski UH (2000) Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J Virol 74:7720–7729.
Holland GN (1999) Immune recovery uveitis. Ocul Immunol Inflamm 7:215–221.
Holtappels R, Podlech J, Grzimek NK, Thomas D, Pahl-Seibert MF, Reddehase MJ (2001) Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65). J Virol 75:6584–6600.
Holtappels R, Grzimek N, Simon C, Thomas D, Dreis D, Reddehase M (2002) Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions. J Virol 76:6044–6053.
Holtappels R, Munks MW, Podlech J, Reddehase MJ (2006) CD8 T-cell -based immunotherapy of cytomegalovirus disease in the mouse model of the immunocompromised bone marrow transplantation recipient. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, UK, pp 383–418.
Horak DA, Schmidt GM, Zaia JA, Niland JC, Ahn C, Forman SJ (1992) Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation. Chest 102:1484–1490.
Horne BD, Muhlestein JB, Carlquist JF, Bair TL, Madsen TE, Hart NI, Anderson JL (2003) Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary disease. Circulation 107:258–263.
Horwitz CA, Henle W, Henle G, Snover D, Rudnick H, Balfour HH, Mazur MH, Watson R, Schwartz B, Muller N (1986) Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine 65:124–134.
Hosenpud JD (1999) Coronary artery disease after heart transplantation and its relation to cytomegalovirus. Am Heart J 138:S469–S472.
Hosenpud JD, Chou SW, Wagner CR (1991) Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation 52:896–903.
Hsich E, Zhou YF, Paigen B, Johnson TM, Burnett MS, Epstein SE (2001) Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein-E knockout mice. Atherosclerosis 156:23–28.
Huang ES, Mar EC, Boldogh I, Baskar J (1984) The oncogenicity of human cytomegalovirus. Birth Defects Orig Artic Ser 20:193–211.
Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J (1991) Vanishing bile-duct syndrome following liver transplantation - is it reversible? Transplantation 51:1004–1010.
Hummel M, Zhang Z, Yan S, DePlaen I, Golia P, Varghese T, Thomas G, Abecassis MI (2001) Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J Virol 75:4814–4822.
Hussain T, Burch M, Fenton MJ, Whitmore PM, Rees P, Elliott M, Aurora P (2007) Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children. Circulation 115:1798–1805.
Hutto C, Little EA, Ricks R, Lee JD, Pass RF (1986) Isolation of cytomegalovirus from toys and hands in a day care center. J Infect Dis 154:527–530.
Iversen AC, Norris PS, Ware CF, Benedict CA (2005) Human NK cells inhibit cytomegalovirus replication through a noncytolytic mechanism involving lymphotoxin-dependent induction of IFN-beta. J Immunol 175:7568–7574.
Jacobson MA, Mills J, Rush J, Peiperl L, Seru V, Mohanty PK, Hopewell PC, Hadley WK, Broadus VC, Leoung G et al (1991) Morbidity and mortality of patients with AIDS and first-episodePneumocystis carinii pneumonia unaffected by concomitant pulmonary cytomegalovirus infection. Am Rev Respir Dis 144:6–9.
Jin X, Demoitie MA, Donahoe SM, Ogg GS, Bonhoeffer S, Kakimoto WM, Gillespie G, Moss PA, Dyer W, Kurilla MG, Riddell SR, Downie J, Sullivan JS, McMichael AJ, Workman C, Nixon DF (2000) High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections. J Infect Dis 181:165–175.
Jonjic S, Pavic I, Polic B, Crnkovic I, Lucin P, Koszinowski UH (1994) Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 179:1713–1717.
Jordan MC, Mar VL (1982) Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus. J Clin Invest 70:762–768.
Kahl M, Siegel-Axel D, Stenglein S, Jahn G, Sinzger C (2000) Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J Virol 74:7628–7635.
Karavellas MP, Lowder CY, Macdonald C, Avila CP Jr, Freeman WR (1998) Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol 116:169–175.
Karavellas MP, Azen SP, MacDonald JC, Shufelt CL, Lowder CY, Plummer DJ, Glasgow B, Torriani FJ, Freeman WR (2001) Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina 21:1–9.
Kas-Deelen AM, de Maar EF, Harmsen MC, Driessen C, van Son WJ, The TH (2000) Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: effect of acute rejection. J Infect Dis 181:721–724.
Kaur A, Hale CL, Noren B, Kassis N, Simon MA, Johnson RP (2002) Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia. J Virol 76: 3646–3658.
Kaur A, Kassis N, Hale CL, Simon M, Elliott M, Gomez-Yafal A, Lifson JD, Desrosiers RC, Wang F, Barry P, Mach M, Johnson RP (2003) Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS. J Virol 77:5749–5758.
Kempen JH, Min YI, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, Jabs DA (2006) Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology 113:684–694.
Kern ER (1999) Animal models for cytomegalovirus infection: murine CMV. In: Zak O, Sande M (eds) Handbook of animal models of infection. Academic Press, London, pp 927–934.
Kessler MJ, London WT, Madden DL, Dambrosia JM, Hilliard JK, Soike KF, Rawlins RG (1989) Serological survey for viral diseases in the Cayo Santiago rhesus macaque population. Puerto Rico Health Sci J 8:95–97.
Khan N, Bruton R, Taylor GS, Cobbold M, Jones TR, Rickinson AB, Moss PA (2005) Identification of cytomegalovirus-specific cytotoxic T lymphocytes in vitro is greatly enhanced by the use of recombinant virus lacking the US2 to US11 region or modified vaccinia virus Ankara expressing individual viral genes. J Virol 79:2869–2879.
Kim SJ, Varghese TK, Zhang Z, Zhao LC, Thomas G, Hummel M, Abecassis M (2005) Renal ischemia/reperfusion injury activates the enhancer domain of the human cytomegalovirus major immediate early promoter. Am J Transplant 5:1606–1613.
King A, Hiby SE, Verma S, Burrows T, Gardner L, Loke YW (1997) Uterine NK cells and trophoblast HLA class I molecules. Am J Reprod Immunol (Copenhagen) 37:459–462.
Kloppenburg G, de Graaf R, Herngreen S, Grauls G, Bruggeman C, Stassen F (2005) Cytomegalovirus aggravates intimal hyperplasia in rats by stimulating smooth muscle cell proliferation. Microbes Infect 7:164–170.
Knight DA, Waldman WJ, Sedmak DD (1999) Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells. Transplantation 68:1814–1818.
Koffron A, Varghese T, Hummel M, Yan S, Kaufman D, Fryer J, Leventhal J, Stuart F, Abecassis M (1999) Immunosuppression is not required for reactivation of latent murine cytomegalovirus. Transplant Proc 31:1395–1396.
Kohara MM, Blum RN (2006) Cytomegalovirus ileitis and hemophagocytic syndrome associated with use of anti-tumor necrosis factor-alpha antibody. Clin Infect Dis 42:733–734.
Komanduri KV, Viswanathan MN, Wieder ED, Schmidt DK, Bredt BM, Jacobson M, McCune JM (1998) Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nature Med 4:953–956.
Komanduri KV, Donahoe SM, Moretto WJ, Schmidt DK, Gillespie G, Ogg GS, Roederer M, Nixon DF, McCune JM (2001a) Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. Virology 279:459–470.
Komanduri KV, Feinberg J, Hutchins RK, Frame RD, Schmidt DK, Viswanathan MN, Lalezari JP, McCune JM (2001b) Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. J Infect Dis 183:1285–1289.
Kondo K, Xu J, Mocarski ES (1996) Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A 93:11137–11142.
Koskinen PK, Nieminen MS, Krogerus LA, Lemstrom KB, Mattila SP, Hayry PJ, Lautenschlager IT (1993) Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J Heart Lung Transplant 12:724–729.
Koskinen PK, Kallio EA, Tikkanen JM, Sihvola RK, Hayry PJ, Lemstrom KB (1999) Cytomegalovirus infection and cardiac allograft vasculopathy. Transplant Infect Dis 1:115–126.
Kovacs A, Weber ML, Burns LJ, Jacob HS, Vercellotti GM (1996) Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am J Pathol 149:1531–1539.
Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science 248:220–223.
Krmpotic A, Messerle M, Crnkovic-Mertens I, Polic B, Jonjic S, Koszinowski UH (2001) The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J Exp Med 190:1285–1296.
Krmpotic A, Busch DH, Bubic I, Gebhardt F, Hengel H, Hasan M, Scalzo AA, Koszinowski UH, Jonjic S (2002) MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol 3:529–535.
Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S (2003) Pathogenesis of murine cytomegalovirus infection. Microbes Infect 5:1263–1277.
Kropff B, Mach M (1997) Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein. J Gen Virol 78:1999–2007.
Kuhn EM, Stolte N, Matz-Rensing K, Mach M, Stahl-Henning C, Hunsmann G, Kaup FJ (1999) Immunohistochemical studies of productive rhesus cytomegalovirus infection in rhesus monkeys (Macaca mulatta) infected with simian immunodeficiency virus. Vet Pathol 36:51–56.
Kurz S, Steffens HP, Mayer A, Harris JR, Reddehase MJ (1997) Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71:2980–2987.
Kurz SK, Rapp M, Steffens HP, Grzimek NK, Schmalz S, Reddehase MJ (1999) Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol 73:482–494.
La Rosa C, Limaye AP, Krishnan A, Longmate J, Diamond DJ (2007) Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease. J Infect Dis 195:633–644.
Lacey SF, Gallez-Hawkins G, Crooks M, Martinez J, Senitzer D, Forman SJ, Spielberger R, Zaia JA, Diamond DJ (2002) Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants. Transplantation 74:722–732.
Lang DJ, Kummer JF (1975) Cytomegalovirus in semen: observations in selected populations. J Infect Dis 132:472–473.
Lanier LL (1999) Natural killer cells fertile with receptors for HLA-G? Proc Natl Acad Sci USA 96:5343–5345.
Lathey JL, Fiscus SA, Rasheed S, Kappes JC, Griffith BP, Elbeik T, Spector SA, Reichelderfer PS (1994) Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases). J Clin Microbiol 32:3064–3067.
Lautenschlager I, Soots A, Krogerus L, Kauppinen H, Saarinen O, Bruggeman C, Ahonen J (1997) CMV increases inflammation and accelerates chronic rejection in rat kidney allografts. Transplant Proc 29:802–803.
Lautenschlager I, Halme L, Hockerstedt K, Krogerus L, Taskinen E (2006) Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations. Transpl Infect Dis 8:21–30.
Lawrence RM, Lawrence RA (2004) Breast milk and infection. Clin Perinatol 31:501–528.
Le Bouteiller P (2000) HLA-G in the human placenta: expression and potential functions. Biochem Soc Trans 28:208–212.
Lemstrom K, Persoons M, Bruggeman C, Ustinov J, Lautenschlager I, Hayry P (1993) Cytomegalovirus infection enhances allograft arteriosclerosis in the rat. Transplant Proc 25:1406–1407.
Lemstrom K, Sihvola R, Bruggeman C, Hayry P, Koskinen P (1997) Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat. Circulation 95:2614–2616.
Lenfant F, Pizzato N, Liang S, Davrinche C, Le Bouteiller P, Horuzsko A (2003) Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice. J Gen Virol 84:307–317.
Libby P, Warner SJ, Friedman GB (1988a) Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 81:487–498.
Libby P, Warner SJ, Salomon RN, Birinyi LK (1988b) Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med 318:1493–1498.
Limaye AP, Huang ML, Leisenring W, Stensland L, Corey L, Boeckh M (2001) Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. J Infect Dis 183:377–382.
Lockridge KM, Sequar G, Zhou SS, Yue Y, Mandell CP, Barry PA (1999) Pathogenesis of experimental rhesus cytomegalovirus infection. J Virol 73:9576–9583.
Lodoen M, Ogasawara K, Hamerman JA, Arase H, Houchins JP, Mocarski ES, Lanier LL (2003) NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med 197:1245–1253.
Loebe M, Schuler S, Zais O et al (1990) Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant 9:707–711.
Lopez-Botet M, Llano M, Ortega M (2001) Human cytomegalovirus and natural killer-mediated surveillance of HLA class I expression: a paradigm of host-pathogen adaptation. Immunol Rev 181:193–202.
Jarvis MA, Borton JA, Keech AM, Wong J, Britt WJ, Magun BE, Nelson JA (2006) Human cytomegalovirus attenuates IL-1B and TNF proinflammatory signaling by inhibition of NFk- B activation. J Virol 80:5588–5596.
Manley TJ, Luy L, Jones T, Boeckh M, Mutimer H, Riddell SR (2004) Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection. Blood 104:1075–1082.
Marchant A, Appay V, Van Der Sande M, Dulphy N, Liesnard C, Kidd M, Kaye S, Ojuola O, Gillespie GM, Vargas Cuero AL, Cerundolo V, Callan M, McAdam KP, Rowland-Jones SL, Donner C, McMichael AJ, Whittle H (2003) Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 111:1747–1755.
Martelius TJ, Blok MJ, Inkinen KA, Loginov RJ, Hockerstedt KA, Bruggeman CA, Lautenschlager IT (2001) Cytomegalovirus infection, viral DNA, and immediate early-1 gene expression in rejecting rat liver allografts. Transplantation 71:1257–1261.
Martelius TJ, Wolff H, Bruggeman CA, Hockerstedt KA, Lautenschlager IT (2002) Induction of cyclo-oxygenase-2 by acute liver allograft rejection and cytomegalovirus infection in the rat. Transpl Int 15:610–614.
Martin-Davila P, Fortun J, Gutierrez C, Marti-Belda P, Candelas A, Honrubia A, Barcena R, Martinez A, Puente A, de Vicente E, Moreno S (2005) Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. J Clin Virol 33:138–144.
McCarthy M, Auger D, He J, Wood C (1998) Cytomegalovirus and human herpesvirus-6 trans-activate the HIV-1 long terminal repeat via multiple response regions in human fetal astrocytes. J Neurovirol 4:495–511.
McCormick AL, Skaletskaya A, Barry PA, Mocarski ES, Goldmacher VS (2003) Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. Virology 316:221–233.
McDonald K, Rector TS, Braulin EA, Kubo SH, Olivari MT (1989) Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 64:359–362.
McLaughlin-Taylor E, Pande H, Forman SJ, Tanamachi B, Li CR, Zaia JA, Greenberg PD, Riddell SR (1994) Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol 43:103–110.
Mehra MR (2006) Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant 6:1248–1256.
Melnick JL, Adam E, Debakey ME (1993) Cytomegalovirus and atherosclerosis. Eur Heart J 14:30–38.
Melnychuk RM, Smith P, Kreklywich CN, Ruchti F, Vomaske J, Hall L, Loh L, Nelson JA, Orloff SL, Streblow DN (2005) Mouse cytomegalovirus M33 is necessary and sufficient in virus-induced vascular smooth muscle cell migration. J Virol 79:10788–10795.
Messerle M, Hahn G, Brune W, Koszinowski UH (2000) Cytomegalovirus bacterial artificial chromosomes: a new herpesvirus vector approach. Adv Virus Res 55:463–478.
Meyers JD, Flournoy N, Thomas ED (1982) Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years’ experience. Rev Infect Dis 4:1119–1132.
Meyers JD, Flournoy N, Thomas ED (1986) Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153:478–488.
Minamishima I, Ueda K, Minematsu T, Minamishima Y, Umemoto M, Take H, Kuraya K (1994) Role of breast milk in acquisition of cytomegalovirus infection. Microbiol Immunol 38:549–552.
Miron D, Brosilow S, Felszer K, Reich D, Halle D, Wachtel D, Eidelman AI, Schlesinger Y (2005) Incidence and clinical manifestations of breast milk-acquired Cytomegalovirus infection in low birth weight infants. J Perinatol 25:299–303.
Mizuta M, Schuster MG (2005) Cytomegalovirus hepatitis associated with use of anti-tumor necrosis factor-alpha antibody. Clin Infect Dis 40:1071–1072.
MMWR (1997) Rubella and congenital rubella syndrome - United States, 1994–1997. MMWR Morb Mortal Wkly Rep 46:350–354.
Moreno TN, Fortunato EA, Hsia K, Spector SA, Spector DH (1997) A model system for human cytomegalovirus-mediated modulation of human immunodeficiency virus type 1 long terminal repeat activity in brain cells. J Virol 71:3693–3701.
Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197–223.
Morris DJ, Martin S, Dyer PA, Hunt L, Mallick NP, Johnson RW (1993) HLA mismatching and cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal allograft recipients. J Med Virol 41:324–327.
Mueller C, Hodgson JM, Bestehorn HP, Brutsche M, Perruchoud AP, Marsch S, Roskamm H, Buettner HJ (2003) Previous cytomegalovirus infection and restenosis after aggressive angioplasty with provisional stenting. J Interv Cardiol 16:307–313.
Muhlemann K, Miller RK, Metlay L, Menegus MA (1992) Cytomegalovirus infection of the human placenta: an immunocytochemical study. Hum Pathol 23:1234–1237.
Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Bair TL, Pearson RR, Anderson JL (2000) Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 102:1917–1923.
Munks MW, Pinto AK, Doom CM, Hill AB (2007) Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J Immunol 178:7235–7241.
Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, Nelson JA, Myers RM, Shenk TE (2003) Coding capacity of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci USA 100:14976–14981.
Murray BM, Subramaniam S (2004) Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients. Transpl Infect Dis 6:3–9.
Myerson D, Hackman RC, Nelson JA et al (1984) Widespread presence of histologically occult cytomegalovirus. Hum Pathol 15:430–439.
Nerheim PL, Meier JL, Vasef MA, Li WG, Hu L, Rice JB, Gavrila D, Richenbacher WE, Weintraub NL (2004) Enhanced cytomegalovirus infection in atherosclerotic human blood vessels. Am J Pathol 164:589–600.
Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, Szklo M (1996) Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94:922–927.
Noda S, Aguirre SA, Bitmansour A, Brown JM, Sparer TE, Huang J, Mocarski ES (2006) Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood 107:30–38.
Noyola DE, Demmler GJ, Nelson CT, Griesser C, Williamson WD, Atkins JT, Rozelle J, Turcich M, Llorente AM, Sellers-Vinson S, Reynolds A, Bale JF Jr., Gerson P, Yow MD (2001) Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 138:325–331.
Onno M, Pangault C, Le Friec G, Guilloux V, Andre P, Fauchet R (2000) Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 164:6426–6434.
Ozono K, Mushiake S, Takeshima T, Nakayama M (1997) Diagnosis of congenital cytomegalovirus infection by examination of placenta: application of polymerase chain reaction and in situ hybridization. Pediatr Pathol Lab Med 17:249–258.
Paavonen T, Mennander A, Lautenschlager I, Mattila S, Hayry P (1993) Endothelialitis and accelerated arteriosclerosis in human heart transplant coronaries. J Heart Lung Transplant 12:117–122.
Pannuti CS, Boas LSV, Angelo MJO, Neto VA, Levi GC, de Mendonca JS, de Godoy CVF (1985) Cytomegalovirus mononucleosis in children and adults: differences in clinical presentation. Scand J Infect Dis 17:153–156.
Pass RF, Stagno S, Dworsky ME, Smith RJ, Alford CA (1982) Excretion of cytomegalovirus in mothers: observation after delivery of congenitally infected and normal infants. J Infect Dis 146:1–6.
Pass RF, Stagno S, Britt WJ, Alford CA (1983) Specific cell mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis 148:953–961.
Pass RF, Little EA, Stagno S, Britt WJ, Alford CA (1987) Young children as a probable source of maternal and congenital cytomegalovirus infection. N Engl J Med 316:1366–1370.
Pecorella I, Ciardi A, Garner A, McCartney AC, Lucas S (2000) Postmortem histological survey of the ocular lesions in a British population of AIDS patients. Br J Ophthalmol 84:1275–1281.
Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, Schall TJ (1999) Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci USA 96:9839–9844.
Pepose JS, Newman C, Bach MC, Quinn TC, Ambinder RF, Holland GN, Hodstrom PS, Frey HM, Foos RY (1987) Pathologic features of cytomegalovirus retinopathy after treatment with the antiviral agent ganciclovir. Ophthalmology 94:414–424.
Percivalle E, Revello MG, Vago L, Morini F, Gerna G (1993) Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest 92:663–670.
Pereira L, Maidji E, McDonagh S, Tabata T (2005) Insights into viral transmission at the uterine-placental interface. Trends Microbiol 13:164–174.
Perlman JM, Argyle C (1992) Lethal cytomegalovirus infection in preterm infants: clinical, radiological, and neuropathological findings. Ann Neurol 31:64–68.
Persoons MC, Daemen MJ, Bruning JH, Bruggeman CA (1994) Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats. A clue to herpesvirus-associated atherogenesis? Circ Res 75:214–220.
Persoons MC, Stals FS, van dam Mieras MC, Bruggeman CA (1998) Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. J Pathol 184:103–199.
Petrakopoulou P, Kubrich M, Pehlivanli S, Meiser B, Reichart B, von Scheidt W, Weis M (2004) Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation 110:11207–11212.
Plachter B, Sinzger C, Jahn G (1996) Cell types involved in replication and distribution of human cytomegalovirus. Adv Virus Res 46:195–261.
Plotkin SA, Starr SE, Friedman HM et al (1989) Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J Infect Dis 159:860–865.
Podlech J, Holtappels R, Pahl-Seibert MF, Steffens HP, Reddehase MJ (2000) Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 74:7496–7507.
Poehlmann TG, Schaumann A, Busch S, Fitzgerald JS, Aguerre-Girr M, Le Bouteiller P, Schleussner E, Markert UR (2006) Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1. Am J Reprod Immunol 56:275–285.
Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, Luccaronin P, Jonjic S, Koszinowski UH (1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188:1047–1054.
Pooley RJ Jr, Peterson L, Finn WG, Kroft SH (1999) Cytomegalovirus-infected cells in routinely prepared peripheral blood films of immunosuppressed patients. Am J Clin Pathol 112:108–112.
Porath A, Schlaeffer F, Sarov I, Keynan A (1987) Cytomegalovirus mononucleosis - a report of 70 cases in a community hospital. Isr J Med Sci 23:268–273.
Potena L, Holweg CT, Chin C, Luikart H, Weisshaar D, Narasimhan B, Fearon WF, Lewis DB, Cooke JP, Mocarski ES, Valantine HA (2006) Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation 82:398–405.
Preblud SR, Alford CA (1990) Rubella. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant, 3rd edn. W.B. Saunders, Philadelphia, pp 197–240.
Prichard MN, Penfold ME, Duke GM, Spaete RR, Kemble GW (2001) A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev Med Virol 11:191–200.
Prod’homme V, Griffin C, Aicheler RJ, Wang EC, McSharry BP, Rickards CR, Stanton RJ, Borysiewicz LK, Lopez-Botet M, Wilkinson GW, Tomasec P (2007) The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1-NK cells. J Immunol 178:4473–4481.
Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y et al (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713–723.
Raeiszadeh M, Webster D, Workman S, Emery VC (2007) The spectrum of CMV associated disease in patients with common variable immunodeficiency. In: 11th International Betaherpesvirus Workshop, Toulouse, France, p 12.
Ranga U, Woffendin C, Yang ZY, Xu L, Verma S, Littman DR, Nabel GJ (1997) Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene. J Virol 71:7020–7029.
Rao NA, Zhang J, Ishimoto S (1998) Role of retinal vascular endothelial cells in development of CMV retinitis. Trans Am Ophthalmol Soc 96:111–123; discussion 124–116.
Rapp M, Messerle M, Buhler B, Tannheimer M, Keil GM, Koszinowski UH (1992) Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. J Virol 66:4399–4406.
Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV (2001) Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis 184: 1461–1464.
Reddehase MJ, Podlech J, Grzimek NK (2002) Mouse models of cytomegalovirus latency: overview. J Clin Virol 25: S23–S36.
Redman TK, Britt WJ, Wilcox CM, Graham MF, Smith PD (2002) Human cytomegalovirus enhances chemokine production by lipopolysaccharide-stimulated lamina propria macrophages. J Infect Dis 185:584–590.
Reinhardt B, Mertens T, Mayr-Beyrle U, Frank H, Luske A, Schierling K, Waltenberger J (2005) HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor. Cardiovasc Res 67:151–160.
Reischig T, Jindra P, Svecova M, Kormunda S, Opatrny K Jr, Treska V (2006) The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection. J Clin Virol 36:146–151.
Reusser P, Attenhofer R, Hebart H, Helg C, Chapuis B, Einsele H (1997) Cytomegalovirus specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood 89:3873–3879.
Reusser P, Riddell SR, Meyers JD, Greenberg PD (1991) Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373–1380.
Richardson WP, Colvin RB, Cheeseman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB, Collins AB, Hirsch MS, McCluskey RT, Russell PS, Rubin RH (1981) Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 305:57–63.
Ricotta D, Alessandri G, Pollara C, Fiorentini S, Favilli F, Tosetti M, Mantovani A, Grassi M, Garrafa E, Dei Cas L, Muneretto C, Caruso A (2001) Adult human heart microvascular endothelial cells are permissive for non-lytic infection by human cytomegalovirus. CardiovascRes 49:440–448.
Rifkind D (1965) Cytomegalovirus infection after renal transplantation. Arch Intern Med 116:554–558.
Rinaldo CR Jr, Kingsley LA, Ho M, Armstrong JA, Zhou SY (1992) Enhanced shedding of cytomegalovirus in semen of human immunodeficiency virus-seropositive homosexual men. J Clin Microbiol 30:1148–1155.
Ross SA, Novak Z, Ashrith G, Rivera LB, Britt WJ, Hedges S, Schwebke JR, Boppana AS (2005) Association between genital tract cytomegalovirus infection and bacterial vaginosis. J Infect Dis 192:1727–1730.
Rubin R (2002) Clinical approach to infection in the compromised host. In: Rubin R, Young LS (eds) Infection in the organ transplant recipient. Kluwer Academic Press, New York, pp 573–679.
Rubin RH, Colvin RB (1986) Cytomegalovirus infection in renal transplantation: clinical importance and control. In: Williams GM, Burdick JF, Solez K (eds) Kidney transplant rejection: diagnosis and treatment. Dekker, New York, pp 283–304.
Rubin RH, Russell PS, Levin M et al (1979) Summary of a workshop on cytomegalovirus infections during organ transplantation. J Infect Dis 139:728–734.
Rue CA, Jarvis MA, Knoche AJ, Meyers HL, DeFilippis VR, Hansen SG, Wagner M, Fruh K, Anders DG, Wong SW, Barry PA, Nelson JA (2004) A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol 78:12529–12536.
Rupp B, Ruzsics Z, Sacher T, Koszinowski UH (2005) Conditional cytomegalovirus replication in vitro and in vivo. J Virol 79:486–494.
Saederup N, Lin YC, Dairaghi DJ, Schall TJ, Mocarski ES (1999) Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci USA 96:10881–10886.
Saez-Lopez C, Ngambe-Tourere E, Rosenzwajg M, Petit JC, Nicolas JC, Gozlan J (2005) Immediate-early antigen expression and modulation of apoptosis after in vitro infection of polymorphonuclear leukocytes by human cytomegalovirus. Microbes Infect 7:1139–1149.
Saffert RT, Kalejta RF (2006) Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80:3863–3871.
Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degre M, Fauchald P, Rollag H (2004) Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 66:329–337.
Salazar-Mather TP, Lewis CA, Biron CA (2002) Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J Clin Invest 110:321–330.
Scalzo AA, Fitzgerald NA, Wallace CR, Gibbons AE, Smart YC, Burton RC, Shellam GR (1992) The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 149:581–589.
Scalzo AA, Corbett AJ, Rawlinson WD, Scott GM, Degli-Esposti MA (2007) The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol 85:46–54.
Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA (1991) A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group. N Eng J Med 324:1005–1011.
Schoppel K, Kropff B, Schmidt C, Vornhagen R, Mach M (1997) The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies. J Infect Dis 175:533–544.
Schoppel K, Schmidt C, Einsele H, Hebart H, Mach M (1998a) Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients. J Infect Dis 178:1233–1243.
Schoppel K, Schmidt C, Einsele H, Hebart H, Mach M (1998b) Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients. J Infect Dis 178:1233–1243.
Schrier RD, Song MK, Smith IL, Karavellas MP, Bartsch DU, Torriani FJ, Garcia CR, Freeman WR (2006) Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis. Retina 26:165–169.
Schust DJ, Tortorella D, Ploegh HL (1999) Viral immunoevasive strategies and trophoblast class I major histocompatibility complex antigens. J Reproduc Immunol 43:243–251.
Schust DJ, Tortorella D, Seebach J, Phan C, Ploegh HL (1998) Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med 188:497–503.
Sedmak DD, Knight DA, Vook NC, Waldman JW (1994) Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 58:1379–1385.
Sequar G, Britt WJ, Lakeman FD, Lockridge KM, Tarara RP, Canfield DR, Zhou SS, Gardner MB, Barry PA (2002) Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis. J Virol 76:7661–7671.
Sester M, Sester U, Gartner B, Heine G, Girndt M, Mueller-Lantzsch N, Meyerhans A, Kohler H (2001) Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 71:1287–1294.
Sester M, Sester U, Gartner B, Kubuschok B, Girndt M, Meyerhans A, Kohler H (2002a) Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J Virol 76:3748–3755.
Sester M, Sester U, Gartner BC, Girndt M, Meyerhans A, Kohler H (2002b) Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection. J Am Soc Nephrol 13:2577–2584.
Sharon-Friling R, Goodhouse J, Colberg-Poley AM, Shenk T (2006) Human cytomegalovirus pUL37×1 induces the release of endoplasmic reticulum calcium stores. Proc Natl Acad Sci USA 103:19117–19122.
Sharples LD, Tamm M, McNeil K, Higenbottam TW, Stewart S, Wallwork J (1996) Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation - early risk factors. Transplantation 61:560–566.
Shen CY, Ho MS, Chang SF, Yen MS, Ng HT, Huang ES, Wu CW (1993) High rate of concurrent genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients. J Infect Dis 168:449–452.
Shen CY, Chang SF, Lin HJ, Ho HN, Yeh TS, Yang SL, Huang ES, Wu CW (1994) Cervical cytomegalovirus infection in prostitutes and in women attending a sexually transmitted disease clinic. J Med Virol 43:362–366.
Shen Y, Zhu H, Shenk T (1997) Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate “hit-and-run” oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci U S A 94:3341–3345.
Shi Y, Tokunaga O (2002) Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int 52:31–39.
Simmen KA, Singh J, Luukkonen BG, Lopper M, Bittner A, Miller NE, Jackson MR, Compton T, Fruh K (2001) Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A 98:7140–7145.
Singh N (2005) Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence. Clin Infect Dis 40:704–708.
Sinzger C, Plachter B, Stenglein S, Jahn G (1993) Immunohistochemical detection of viral antigens in smooth muscle, stromal, and epithelial cells from acute human cytomegalovirus gastritis. J Infect Dis 167:1427–1432.
Sinzger C, Grefte A, Plachter B, Gouw AS, The TH, Jahn G (1995) Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 76:741–750.
Sinzger C, Plachter B, Grefte A, The TH, Jahn G (1996) Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis 173:240–245.
Sinzger C, Bissinger AL, Viebahn R, Oettle H, Radke C, Schmidt CA, Jahn G (1999a) Hepatocytes are permissive for human cytomegalovirus infection in human liver cell culture and In vivo. J Infect Dis 180:976–986.
Sinzger C, Schmidt K, Knapp J, Kahl M, Beck R, Waldman J, Hebart H, Einsele H, Jahn G (1999b) Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J Gen Virol 80:2867–2877.
Smith LM, Shellam GR, Redwood AJ (2006) Genes of murine cytomegalovirus exist as a number of distinct genotypes. Virology 352:450–465.
Smith PD, Saini SS, Raffeld M, Manischewitz JF, Wahl SM (1992) Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages. J Clin Invest 90:1642–1648.
Smyth RL, Scott JP, Borysiewicz LK, Sharples LD, Stewart S, Wreghitt TG, Gray JJ, Higenbottam TW, Wallwork J (1991) Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment. J Infect Dis 164:1045–1050.
Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL, Levey AS, Strom TB, Carpenter CE, Levey RH, Harmon WE, Zimmerman CE, Shaprio ME, Steinman T, LoGerfo F, Idelson B, Schroter GPJ, Levin MJ, McIver J, Leszczynski J, Grady GF (1987) Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal transplant recipients. N Engl J Med 317:1049–1054.
Soderberg-Naucler C, Fish KN, Nelson JA (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119–126.
Sohn YM, Oh MK, Balcarek KB, Cloud GA, Pass RF (1991) Cytomegalovirus infection in sexually active adolescents. J Infect Dis 163:460–463.
Sohn YM, Park KI, Lee C, Han DG, Lee WY (1992) Congenital cytomegalovirus infection in Korean population with very high prevalence of maternal immunity. J Kor Med Sci 7:47–51.
Sola R, Diaz JM, Guirado L, Ravella N, Vila L, Sainz Z, Gich I, Picazo M, Garcia R, Abreu E, Ortiz F, Alcaraz A (2003) Significance of cytomegalovirus infection in renal transplantation. Transplant Proc 35:1753–1755.
Soots A, Lautenschlager I, Krogerus L, Saarinen O, Ahonen J (1998) An experimental model of chronic renal allograft rejection in the rat using triple drug immunosuppression. Transplantation 65:42–46.
Sorlie PD, Nieto FJ, Adam E, Folsom AR, Shahar E, Massing M (2000) A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med 160:2027–2032.
Span AH, van Dam-Mieras MC, Mullers W, Endert J, Muller AD, Bruggeman CA (1991) The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur J Clin Invest 21:331–338.
Spector SA, Hsia K, Crager M, Pilcher M, Cabral S, Stempien MJ (1999) Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS. J Virol 73:7027–7030.
Spector SA, Wong R, Hsia K, Pilcher M, Stempien MJ (1998) Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J Clin Invest 101:497–502.
Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391–394.
Srivastava R, Curtis M, Hendrickson S, Burns WH, Hosenpud JD (1999) Strain specific effects of cytomegalovirus on endothelial cells: implications for investigating the relationship between CMV and cardiac allograft vasculopathy. Transplantation 68:1568–1573.
Stagno S, Britt WJ (2006) Cytomegalovirus. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant, 6th edn. W.B. Saunders, Philadelphia.
Stagno S, Reynolds DW, Tsiantos A, Fucillo DA, Long W, Alford CA (1975) Comparative, serial virologic and serologic studies of symptomatic and subclinical congenital and natally acquired cytomegalovirus infection. J Infect Dis 132:568–577.
Stagno S, Reynolds DW, Pass RF, Alford CA (1980) Breast milk and the risk of cytomegalovirus infection. N Engl J Med 302:1073–1076.
Stagno S, Pass RF, Dworsky ME, Alford CA (1982a) Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol 25:563–576.
Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, Walton PD, Alford CA (1982b) Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N Eng J Med 306:945–949.
Stagno S, Pass RF, Dworsky ME, Alford CA (1983) Congenital and perinatal cytomegaloviral infections. Semin Perinatol 7:31–42.
Stals FS (1999) Animal models for cytomegalovirus infection: Rat CMV. In: Zak O, Sande M (eds) Handbook of animal models of infection. Academic Press, London, pp 943–950.
Stals FS, Bosman F, van Boven CP, Bruggeman CA (1990) An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Arch Virol 114:91–107.
Starr SE, Tolpin MD, Friedman HM, Paucker K, Plotkin SA (1979) Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers. J Infect Dis 140:500–505.
Stassen FR, Vega-Cordova X, Vliegen I, Bruggeman CA (2006) Immune activation following cytomegalovirus infection: more important than direct viral effects in cardiovascular disease? J Clin Virol 35:349–353.
Stoica SC, Cafferty F, Pauriah M, Taylor CJ, Sharples LD, Wallwork J, Large SR, Parameshwar J (2006) The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. J Heart Lung Transplant 25:420–425.
Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y, Nelson JA (1999) The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99:511–520.
Streblow DN, van Cleef KW, Kreklywich CN, Meyer C, Smith P, Defilippis V, Grey F, Fruh K, Searles R, Bruggeman C, Vink C, Nelson JA, Orloff SL (2007) Rat cytomegalovirus gene expression in cardiac allograft recipients is tissue specific and does not parallel the profiles detected in vitro. J Virol 81:3816–3826.
Swack NS, Hsiung GD (1982) Natural and experimental simian cytomegalovirus infections at a primate center. J Med Primatol 11:169–177.
Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, Sleath PR, Grabstein KH, Hosken NA, Kern F, Nelson JA, Picker LJ (2005) Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202:673–685.
Tabiasco J, Rabot M, Aguerre-Girr M, El Costa H, Berrebi A, Parant O, Laskarin G, Juretic K, Bensussan A, Rukavina D, Le Bouteiller P (2006) Human decidual NK cells: unique phenotype and functional properties - a review. Placenta 27 Suppl A:S34–S39.
Tarantal AF, Salamat MS, Britt WJ, Luciw PA, Hendrickx AG, Barry PA (1998) Neuropathogenesis induced by rhesus cytomegalovirus in fetal rhesus monkeys (Macaca mulatta). J Infect Dis 177:446–450.
Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72:2059–2064.
Taylor-Wiedeman J, Sissons P, Sinclair J (1994) Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol 68:1597–1604.
Taylor PM, Rose ML, Yacoub MH, Pigott R (1992) Induction of vascular adhesion molecules during rejection of human cardiac allografts. Transplantation 54:451–457.
Tomazin R, Boname J, Hegde NR, Lewinsohn DM, Altschuler Y, Jones TR, Cresswell P, Nelson JA, Riddell SR, Johnson DC (1999) Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med 5:1039–1043.
Tong CY, Bakran A, Peiris JS, Muir P, Herrington CS (2002) The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation 74:576–578.
Torriani FJ, Freeman WR, Macdonald JC, Karavellas MP, Durand DM, Jeffrey DD, Meylan PR, Schrier RD (2000) CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy. AIDS 14:173–180.
Tu W, Potena L, Stepick-Biek P, Liu L, Dionis KY, Luikart H, Fearon WF, Holmes TH, Chin C, Cooke JP, Valantine HA, Mocarski ES, Lewis DB (2006) T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation 114:1608–1615.
Tumilowicz JJ (1990) Characteristics of human arterial smooth muscle cell cultures infected with cytomegalovirus. In Vitro Cel Dev Biol 26:1144–1150.
Tumilowicz JJ, Gawlik ME, Powell BB, Trentin JJ (1985) Replication of cytomegalovirus in human arterial smooth muscle cells. J Virol 56:839–845.
Valantine HA (2004) The role of viruses in cardiac allograft vasculopathy. Am J Transplant 4:169–177.
Valantine HA, Gao SZ, Menon SG, Renlund DG, Hunt SA, Oyer P, Stinson EB, Brown BW Jr, Merigan TC, Schroeder JS (1999) Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation 100:61–66.
Valchanova RS, Picard-Maureau M, Budt M, Brune W (2006) Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis. J Virol 80:10181–10190.
Van Dam-Mieras MC, Bruggeman CA, Muller AD, Debie WH, Zwaal RF (1987) Induction of endothelial cell procoagulant activity by cytomegalovirus infection. Thromb Res 47:69–75.
Vazquez-Martul E, Mosquera JM, Rivera CF, Hernandez AA, Pertega S (2004) Histological features with clinical impact in chronic allograft nephropathy: review of 66 cases. Transplant Proc 36:770–771.
Vliegen I, Duijvestijn A, Grauls G, Herngreen S, Bruggeman C, Stassen F (2004) Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation. Microbes Infect 6:17–24.
Vochem M, Hamprecht K, Jahn G, Speer CP (1998) Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J 17:53–58.
Vogel P, Weigler BJ, Kerr H, Hendrickx AG, Barry PA (1994) Seroepidemiologic studies of cytomegalovirus infection in a breeding population of rhesus macaques. Lab Anim Sci 44:25–30.
Voigt V, Forbes CA, Tonkin JN, Degli-Esposti MA, Smith HR, Yokoyama WM, Scalzo AA (2003) Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A 100:13483–13488.
Wagner CS, Riise GC, Bergstrom T, Karre K, Carbone E, Berg L (2007) Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J Immunol 178:3536–3543.
Waldrop SL, Pitcher CJ, Peterson DM, Maino VC, Picker LJ (1997) Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry. Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 99:1739–1750.
Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333:1038–1044.
Wang D, Shenk T (2005a) Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J Virol 79:10330–10338.
Wang D, Shenk T (2005b) Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci U S A 102:18153–18158.
Webster A, Lee CA, Cook DG, Grundy JE, Emery VC, Kernoff PB, Griffiths PD (1989) Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet 2:63–66.
Weller TH (1971a) The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I. N Eng J Med 285:203–214.
Weller TH (1971b) The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II. N Eng J Med 285:267–274.
Westphal M, Lautenschlager I, Backhaus C, Loginov R, Kundt G, Oberender H, Stamm C, Steinhoff G (2006) Cytomegalovirus and proliferative signals in the vascular wall of CABG patients. Thorac Cardiovasc Surg 54:219–226.
Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT Jr, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA (1999) Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. JAMA 282:1633–1637.
Wilcox CM, Chalasani N, Lazenby A, Schwartz DA (1998) Cytomegalovirus colitis in acquired immunodeficiency syndrome: a clinical and endoscopic study. Gastrointest Endos 48:39–43.
Wiley CA, Nelson JA (1988) Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. Am J Pathol 133:73–81.
Willeitner A (2004) Transmission of cytomegalovirus (CMV) through human milk: are new breastfeeding policies required for preterm infants? Adv Exp Med Biol 554:489–494.
Wills MR, Ashiru O, Reeves MB, Okecha G, Trowsdale J, Tomasec P, Wilkinson GW, Sinclair J, Sissons JG (2005) Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J Immunol 175:7457–7465.
Wreghitt TG, Hakim M, Gray JJ et al (1988) Cytomegalovirus infections in heart and heart and lung transplant recipients. J Clin Pathol 41:660–667.
Wreghitt TG, Abel SJ, McNeil K, Parameshwar J, Stewart S, Cary N, Sharples L, Large S, Wallwork J (1999) Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients. Transplant Int 12:254–260.
Wu GD, Shintaku IP, Chien K, Geller SA (1989) A comparison of routine light microscopy, immunohistochemistry and in situ hybridization for the detection of cytomegalovirus in gastrointestinal biopsies. Am J Gastroenterol 84:1517–1520.
Wu TC, Hruban RH, Ambinder RF, Pizzorno M, Cameron DE, Baumgartner WA, Reitz BA, Hayward GS, Hutchins GM (1992) Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol 140:739–747.
Yamamoto AP, Mussi-Pinhata MM, Pinto PC, Figueiredo LT, Jorge SM (2001) Congenital cytomegalovirus infection in preterm and full-term newborn infants from a population with a high seroprevalence rate. Pediatr Infect Dis J 20:188–192.
Ye M, Morello CS, Spector DH (2002) Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge. J Virol 76:2100–2112.
Yilmaz S, Koskinen PK, Kallio E, Bruggeman CA, Hayry PJ, Lemstrom KB (1996) Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression. Kidney Int 50:526–537.
Yokoyama WM, Scalzo AA (2002) Natural killer cell activation receptors in innate immunity to infection. Microbes Infect 4:1513–1521.
Yow MD, Williamson DW, Leeds LJ, Thompson P, Woodward RM, Walmus BF, Lester JW, Six HR, Griffiths PD (1988) Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol 158:1189–1195.
Yu D, Silva MC, Shenk T (2003) Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci U S A 100:12396–12401.
Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE (1996) Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 335:624–630.
Zhou YF, Shou M, Guetta E, Guzman R, Unger EF, Yu ZX, Zhang J, Finkel T, Epstein SE (1999) Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation 100:1569–1575.
Zhu H, Shen Y, Shenk T (1995) Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 69:7960–7970.
Zhu H, Cong JP, Mamtora G, Gingeras T, Shenk T (1998) Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci U S A 95:14470–14475.
Zhu H, Cong JP, Bresnahan WA, Shenk TE (2002) Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci U S A 99:3932–3937.
Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE (2001) Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103:45–51.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Britt, W. (2008). Manifestations of Human Cytomegalovirus Infection: Proposed Mechanisms of Acute and Chronic Disease. In: Shenk, T.E., Stinski, M.F. (eds) Human Cytomegalovirus. Current Topics in Microbiology and Immunology, vol 325. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77349-8_23
Download citation
DOI: https://doi.org/10.1007/978-3-540-77349-8_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-77348-1
Online ISBN: 978-3-540-77349-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)